| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/25/2011 | CA2495743C Fusion proteins and methods of producing same |
| 01/25/2011 | CA2490141C 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 01/25/2011 | CA2476983C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma |
| 01/25/2011 | CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2432582C Sulfamidothienopyrimidines |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2340786C Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 01/25/2011 | CA2337857C Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
| 01/25/2011 | CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use |
| 01/25/2011 | CA2317455C Hydroxamic and carboxylic acid derivatives |
| 01/25/2011 | CA2295540C Improved anti-ige antibodies and method of improving polypeptides |
| 01/20/2011 | WO2011009075A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | WO2011009047A2 Il-1ra-polymer conjugates |
| 01/20/2011 | WO2011008947A2 Treatment and diagnosis of immune disorders |
| 01/20/2011 | WO2011008709A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | WO2011008487A1 Pyrimidinones as pi3k inhibitors |
| 01/20/2011 | WO2011008086A1 Mixture of non-digestible oligosaccharides for stimulating the immune system |
| 01/20/2011 | WO2011007961A2 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes |
| 01/20/2011 | WO2011007867A1 Fish feed |
| 01/20/2011 | WO2011007794A1 Zeolite and sericite-containing composition for medical or medical assisting uses |
| 01/20/2011 | WO2011007747A1 Sugar chain-added ailim extracellular domain and method for producing same |
| 01/20/2011 | WO2011007633A1 Crystals of pyrroloquinolinequinone sodium salts |
| 01/20/2011 | WO2011007324A1 Pyridin-4-yl derivatives |
| 01/20/2011 | WO2011006980A1 Method for inhibiting the maturation of dendritic cells |
| 01/20/2011 | WO2011006936A1 Tricyclic indole-derived spiro derivatives as crth2 modulators |
| 01/20/2011 | WO2011006935A2 Tetrazole derivatives |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015263 Therapeutic delivery of carbon monoxide |
| 01/20/2011 | US20110015228 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/20/2011 | US20110015219 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof |
| 01/20/2011 | US20110015195 Aryl ureas with angiogenisis inhibiting activity |
| 01/20/2011 | US20110015184 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 01/20/2011 | US20110015183 Substituted pyrazole sigma receptor antagonists |
| 01/20/2011 | US20110015180 Chemokine receptor antagonists |
| 01/20/2011 | US20110015165 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
| 01/20/2011 | US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/20/2011 | US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses |
| 01/20/2011 | US20110015154 Supporting acetylcholine function |
| 01/20/2011 | US20110014281 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 01/20/2011 | US20110014274 Vaccine composition containing synthetic adjuvant |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014241 Therapeutic Cancer Antigens |
| 01/20/2011 | US20110014240 Single cycle replicating adenovirus vectors |
| 01/20/2011 | US20110014239 Preparation of Vaccines Using Photosensitizer and Light |
| 01/20/2011 | US20110014238 Immunogenic protein pas n 1 from bahia grass pollen |
| 01/20/2011 | US20110014237 Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets |
| 01/20/2011 | US20110014234 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 01/20/2011 | US20110014230 preparation of influenza virus vaccine antigens |
| 01/20/2011 | US20110014228 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 01/20/2011 | US20110014226 high throughput protein interaction assay |
| 01/20/2011 | US20110014224 Methods for producing an immune response to tuberculosis |
| 01/20/2011 | US20110014218 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 01/20/2011 | US20110014217 Carbon nanotube compositions and methods of use thereof |
| 01/20/2011 | US20110014215 Granulysin and uses thereof |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014209 Recombinant hcv e2 glycoprotein |
| 01/20/2011 | US20110014199 Novel anti-il 13 antibodies and uses thereof |
| 01/20/2011 | US20110014190 Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance |
| 01/20/2011 | US20110014189 Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents |
| 01/20/2011 | US20110014188 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 01/20/2011 | US20110014185 Methods involving graf polypeptides |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014159 Method for obtaining characterized muscle-derived cell populations and uses |
| 01/20/2011 | US20110014156 Bifidobacterium for dust mite allergy |
| 01/20/2011 | US20110014152 Increased t-cell tumor infiltration and eradication of metastases by mutant light |
| 01/20/2011 | US20110014128 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110011392 Olopatadine nasal spray regimen for children |
| 01/20/2011 | DE102009033208A1 Aminopyridinderivate Aminopyridine |
| 01/20/2011 | CA2768460A1 Antagonists, uses & methods for partially inhibiting tnfr1 |
| 01/20/2011 | CA2768368A1 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 01/20/2011 | CA2767894A1 Apoptosis signal-regulating kinase inhibitors |
| 01/20/2011 | CA2767585A1 Pyridin-4-yl derivatives |
| 01/20/2011 | CA2766883A1 Tricyclic indole-derived spiro derivatives as crth2 modulators |
| 01/20/2011 | CA2766874A1 Tetrazole derivatives |
| 01/20/2011 | CA2766100A1 Pyrimidinones as pi3k inhibitors |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275535A1 Animal cells and processes for the replication of influenza viruses |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275441A1 High affinity HIV T cell receptors |
| 01/19/2011 | EP2275413A1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders. |
| 01/19/2011 | EP2275134A2 Use of ADCC-optimized antibodies for treating weak patients |
| 01/19/2011 | EP2275133A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
| 01/19/2011 | EP2275114A1 Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 01/19/2011 | EP2275107A2 Combinations for the treatment of diseases involving cell proliferation |
| 01/19/2011 | EP2275101A1 Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP2274326A1 Suppressor of the endogenous interferon- gamma |
| 01/19/2011 | EP2274053A2 Use of the human pancreatic polypeptide as a therapeutic agent |
| 01/19/2011 | EP1940418B1 Sulfatides for treatment of autoimmune disorders |
| 01/19/2011 | EP1668036B1 Method for the production of human antibodies blocking the biological activity of a human cytokine |
| 01/19/2011 | EP1581509B1 1-(amino)indanes as edg receptor agonists |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1448995B1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |